Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China flag China · Delayed Price · Currency is CNY
6.43
+0.08 (1.26%)
May 19, 2026, 10:25 AM CST

SHE:300639 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
768.35798.56712.36764.931,025521.97
Short-Term Investments
--250.29---
Trading Asset Securities
182.52240.150.63307.05387.06677.14
Cash & Short-Term Investments
950.871,039963.271,0721,4121,199
Cash Growth
38.50%7.83%-10.14%-24.07%17.74%-4.14%
Accounts Receivable
667.29701.41,0991,8912,7251,116
Other Receivables
18.2414.4510.9813.5616.3214.53
Receivables
685.53715.841,1101,9042,7421,131
Inventory
70.8161.8665.6699.56118.74147.14
Prepaid Expenses
--0.015.115.5423.37
Other Current Assets
80.6277.6987.0996.13112.4451.95
Total Current Assets
1,7881,8942,2263,1774,4002,552
Property, Plant & Equipment
1,2911,3151,4081,4371,3171,168
Long-Term Investments
524.85531.93545.71533.12521.98273.81
Other Intangible Assets
249.88252.7259.28249.58185.21100.14
Long-Term Deferred Tax Assets
63.5266.7786.32195.35180.2529.2
Long-Term Deferred Charges
56.565660.979.9581.6182.62
Other Long-Term Assets
244.8331.5437.6153.554.8925.58
Total Assets
4,2234,1484,6235,7266,7414,231
Accounts Payable
90.1986.36106.75143.67466.69221.15
Accrued Expenses
45.7847.7172.6585.83399.86174.96
Short-Term Debt
6.126.8221.632.1298.48151.5
Current Portion of Long-Term Debt
-6.26----
Current Portion of Leases
--7.918.8610.486.79
Current Income Taxes Payable
-10.18.378.1352.7194.88
Current Unearned Revenue
9.4710.9614.868.9322.1613.16
Other Current Liabilities
185.78184.1209.46180.412.4615.15
Total Current Liabilities
337.33352.33441.55507.921,363677.59
Long-Term Debt
73.2973.2452.7928.27--
Long-Term Leases
3.373.245.1917.430.5326.86
Long-Term Unearned Revenue
6.436.949.1511.8214.1316.56
Long-Term Deferred Tax Liabilities
81.1647.8767.0761.6106.1435.36
Other Long-Term Liabilities
2.252.250.690.05--
Total Liabilities
503.83485.86576.44627.051,514756.37
Common Stock
646.5646.5646.5649.15439.52293.89
Additional Paid-In Capital
652.96667.11785.49877.521,1901,280
Retained Earnings
2,4172,4202,5513,2473,2581,634
Treasury Stock
-110.15-110.15-65.13-100-149.99-99.99
Comprehensive Income & Other
199.84125.1191.85187.26169.8486.73
Total Common Equity
3,8063,7484,1094,8614,9073,194
Minority Interest
-86.57-86.54-62.9237.46320.38280.63
Shareholders' Equity
3,7203,6624,0475,0995,2283,475
Total Liabilities & Equity
4,2234,1484,6235,7266,7414,231
Total Debt
82.7889.5687.5156.65139.49185.15
Net Cash (Debt)
868.09949.15875.761,0151,2721,014
Net Cash Growth
56.16%8.38%-13.75%-20.20%25.48%-13.74%
Net Cash Per Share
1.391.521.36-1.931.54
Filing Date Shares Outstanding
650.35575.05635.3-651.68655.3
Total Common Shares Outstanding
650.35575.05635.3-651.68655.3
Working Capital
1,4501,5421,7842,6693,0371,875
Book Value Per Share
5.856.526.47-7.534.87
Tangible Book Value
3,5513,4963,8504,6124,7223,094
Tangible Book Value Per Share
5.466.086.06-7.254.72
Buildings
--1,1151,070991.09786.57
Machinery
--701.8683.89600.83521.92
Construction In Progress
--232.59171.3858.6238.29
Source: S&P Global Market Intelligence. Standard template. Financial Sources.